About Borealis Biosciences, Inc.
RNA Medicines for Kidney Disease
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Founded
- 2024
- Company type
- Privately Held
Borealis Biosciences was founded on the premise that a convergence of scientific and translational breakthroughs is enabling the field of RNA medicines to treat kidney diseases and beyond. The company is backed by founding investor Versant Ventures and Novartis AG, and has a strategic collaboration with the pharma.
Business areas
- Biotechnology
- Life Science
- Medical
On LinkedIn
- Followers
- 7,222
- People linked to this company
- 54
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Funding raised
180,000,000 USD
Total reported by Crunchbase, in US dollars. This is funding raised, not company revenue or valuation.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.